Could Novavax's Next Step Make It a Multibagger?

Could Novavax's Next Step Make It a Multibagger?
·4 min read

Novavax disappointed investors when its regulatory submissions fell behind. Now, all eyes are on Novavax's next step: winning authorization in the U.S. Could this nudge the stock out of its slump -- and even turn it into a multibagger? Novavax reported revenue of $704 million and net income of $203 million.